Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

High copays keep many heart failure patients from filling needed prescriptions

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

CMS issues workplace violence memorandum for hospitals

CMS has fined hospitals in the past for failing to meet the standards of safe settings under the Medicare Hospital Conditions of Participation.

 

WHO renames monkeypox disease

Human monkeypox disease was given its name in 1970, before WHO established best practices for naming diseases in 2015.

Thumbnail

Digital health startup receives FDA clearance for Parkinson’s Disease applications on Apple Watch

The U.S. Food and Drug Administration (FDA) has approved 501(k) marketing clearance for the prescription mobile app Parky for monitoring Parkinson’s Disease.

Lawmakers urge DOJ to act on anti-trans threats at children’s hospitals

Dozens of lawmakers banded together to urge the Department of Justice to act on rising anti-transgender threats made against the nation’s children’s hospitals.

Thumbnail

New signups rise 40% on healthcare marketplace

In the first few weeks of open enrollment, new signups on the healthcare marketplace, healthcare.gov, are up nearly 40%, according to the Department of Health and Human Services (HHS).

hearing aid

UnitedHealth, AARP team up for hearing aid savings

UnitedHealthcare has teamed up with AARP to administer hearing aid solutions, including prescription and over-the-counter (OTC) hearing aids.

Thumbnail

AMA opposes criminalization of pregnancy loss

The American Medical Association (AMA) released a number of new policy adoptions, including several in reaction to the recently changed reproductive health laws in the United States.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.